MarketPulse

liver injury

2 articles
BenzingaBenzinga··Vandana Singh

Amgen's Japanese Partner Issues Caution Alert on Tavneos Amid FDA Safety Concerns

Kissei Pharmaceutical urges caution on Tavneos use following FDA safety warnings and data integrity concerns, proposing withdrawal of the Amgen drug's approval.
AMGNclinical trialdrug safety
BenzingaBenzinga··Vandana Singh

Amgen's Tavneos Faces FDA Warning Over Fatal Liver Injuries

FDA warns of 76 drug-induced liver injury cases linked to Amgen's Tavneos, including 8 deaths and severe bile duct syndrome, raising significant safety and commercial concerns.
AMGNFDA warningliver injury